1. Ann H. Partridge, Shari Gelber, Eric P. Winer, and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Martine J. Piccart-Gebhart and Florine Focant, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Matthew Scullion, Roche, Welwyn Garden City; and Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom.